References
- Miller LC. International adoption: infectious
diseases issues. Clin Infect Dis. 2005;40:286-93.
[ PubMed
Abstract]
- Hoofnagle JH. Serologic markers of hepatitis
B virus infection. Annu Rev Med. 1981;32:1-11.
[ PubMed
Abstract]
- Ribeiro RM, Lo A, Perelson AS. Dynamics
of hepatitis B virus infection. Microbes Infect. 2002;4:829-35.
[ PubMed
Abstract]
- Ganem D, Prince AM. Hepatitis B virus infection—natural
history and clinical consequences. N Engl J Med. 2004;350:1118-29.
[ PubMed
Abstract]
- Lok AS, McMahon BJ. Chronic hepatitis B: update
of recommendations. Hepatology. 2004;39:857-61.
[ PubMed
Abstract]
- McMahon BJ. The natural history of chronic
hepatitis B virus infection. Semin Liver Dis. 2004;24(Suppl 1):17-21.
[ PubMed
Abstract]
- Hsu YS, Chien RN, Yeh CT, et al. Long-term
outcome after spontaneous HBeAg seroconversion in patients with chronic
hepatitis B. Hepatology. 2002;35:1522-7.
[ PubMed
Abstract]
- Hoofnagle JH, Dusheiko GM, Seeff LB, Jones
EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen
to antibody in chronic type B hepatitis. Ann Intern Med. 1981;94:744-8.
[ PubMed
Abstract]
- Yang HI, Lu SN, Liaw YF, et al. Hepatitis
B e antigen and the risk of hepatocellular carcinoma. N Engl J Med.
2002;347:168-74.
[ PubMed
Abstract]
- Lin CL, Liao LY, Liu CJ, et al. Hepatitis
B genotypes and precore/basal core promoter mutants in HBeAg-negative
chronic hepatitis B. J Gastroenterol 2002;37:283-7.
[ PubMed
Abstract]
- Keeffe EB, Dieterich DT, Han SH, et al. A treatment
algorithm for the management of chronic hepatitis B virus infection in
the United States. Clin Gastroenterol Hepatol. 2004;2:87-106.
[ PubMed
Abstract]
[Back
to Question | Back to Discussion]
CME Credit | CNE
Credit
| Back to Top |